Concepedia

Ronja Wieboldt

RW

Statistics

Publications

7

Citations

284

H-Index

7

Active since

2018

Affiliations

University Hospital of Basel(Current)

University of Basel

ETH Zurich

SIB Swiss Institute of Bioinformatics

University of Zurich

Ronja Wieboldt is an author at University Hospital of Basel specializing in medicine, cancer immunotherapy, and oncology.

Publications per year

2018–2024

7

Publications

7

Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma

Philip Schmassmann, Julien Roux, Alicia Buck et al. · Science Translational Medicine · 2023 · 77 citations

, , +17

Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer

Jinyu Wang, Michela Manni, Anne Bärenwaldt et al. · Frontiers in Cell and Developmental Biology · 2022 · 52 citations · Full text

, , +17

Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2

Ronja Wieboldt, Michael T. Sandholzer, Emanuele Carlini et al. · Cellular and Molecular Immunology · 2024 · 42 citations · Full text

, , +17

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

Tomás A. Martins, Deniz Kaymak, Nazanin Tatari et al. · Nature Communications · 2024 · 39 citations · Full text

, , +11

The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer

Detlef K. Bartsch, Norman Gercke, Konstantin Strauch et al. · Journal of Clinical Medicine · 2018 · 37 citations · Full text

, , +17

1–5 of 7